Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      New Resources on Managing Obesity-Related Challenges of Cancer Patients for Providers, Patients

      May 13, 2014
      By Christina Izzo
      Article

      The American Society of Clinical Oncology has released new resources to help healthcare providers and patients manage the complications of obesity in patients with cancer, the organization announced.

      The American Society of Clinical Oncology has released new resources to help healthcare providers and patients manage the complications of obesity in patients with cancer, the organization announced.

      The patient guide, "Managing Your Weight After a Cancer Diagnosis," and the healthcare practitioner guide, "Obesity and Cancer: A Guide for Oncology Providers," are designed to help manage the complications of obesity in patients with cancer and facilitate communication about the importance of weight management and making healthy lifestyle choices following a cancer diagnosis.

      In a similar vein, the Oncology Nursing Society (ONS) recently introduced its “Get Up, Get Moving,” campaign at the organization’s annual meeting held May 1-4, the goal of which is to increase the number of patients who receive safe and effective recommendations from their nurses to participate in physical activity.

      "Obesity is a defining public health challenge for our nation today," ASCO President Clifford A. Hudis, MD, FACP, said in a statement "As oncologists, we have an obligation to take on this challenge, providing ways to reduce the risk of obesity-related cancers, and equipping physicians and patients with the education and tools they need to ensure everyone receives the best possible cancer care."

      Obesity has been linked with an increased risk for many of the most common cancers, including breast, colon, and high-grade prostate cancers and has been linked to poorer outcomes among patients diagnosed with cancer, including higher risk of side effects, cancer recurrence, and mortality.

      The new guides feature a range of tools and information, such as recommendations for providers to help them assist overweight and obese cancer survivors to access resources and services to lose weight and become more active, details on obesity-related services available through the Affordable Care Act, and tools to help clinicians and patients communicate effectively about common challenges patients face.

      The provider guide and other resources are now available on ASCO's website, at www.asco.org/obesity

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with brown hair and bangs, surrounded by a blue border
      Photo of an open bottle of pills
      4 experts in this video
      4 experts in this video
      Photo of a woman wearing a blazer and a colorful scarf in front of a blue background
      Related Content

      Graphic of a seal that reads "FDA Approved"

      July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More

      Bridget Hoyt
      August 2nd 2025
      Article

      New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.


      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      August 2nd 2025
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.


      Graphic of malignant B cells

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Chris Ryan
      August 2nd 2025
      Article

      Adding sonrotoclax to zanubrutinib led to deep and durable response in relapsed or refractory mantle cell lymphoma, according to EHA Congress data.


      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      August 2nd 2025
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.


      Line illustration of lungs

      Opinion: Comprehensive Genomic Profiling Is Vital for Optimizing NSCLC Care

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      August 2nd 2025
      Article

      Oncology nurses can ensure patients with non–small cell lung cancer receive the optimal treatment quickly by understanding comprehensive genomic profiling.


      Graphic of a person with lung tumors

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Bridget Hoyt
      August 2nd 2025
      Article

      2025 ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become more widely used.

      Related Content

      Graphic of a seal that reads "FDA Approved"

      July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More

      Bridget Hoyt
      August 2nd 2025
      Article

      New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.


      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      August 2nd 2025
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.


      Graphic of malignant B cells

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Chris Ryan
      August 2nd 2025
      Article

      Adding sonrotoclax to zanubrutinib led to deep and durable response in relapsed or refractory mantle cell lymphoma, according to EHA Congress data.


      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      August 2nd 2025
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.


      Line illustration of lungs

      Opinion: Comprehensive Genomic Profiling Is Vital for Optimizing NSCLC Care

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      August 2nd 2025
      Article

      Oncology nurses can ensure patients with non–small cell lung cancer receive the optimal treatment quickly by understanding comprehensive genomic profiling.


      Graphic of a person with lung tumors

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Bridget Hoyt
      August 2nd 2025
      Article

      2025 ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become more widely used.

      Latest Conference Coverage

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer

      Understanding How On-Target and Off-Target ADC Toxicities Work

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.